Regulation 1107/2009: Lessons learned after 5 years Dr. Martin Streloke, BVL Brussels, 9. March 2016 Experiences with implemeting 1107/2009 • Much more exchange between MS • Administrative procedures, reporting, responsibilities have been harmonised considerably • Even criteria for risk assessment and decision-making have been developed further • Additional committees for discussing critical items were established and MS met frequently • A lot of zonal authorisations habe been granted • Number of approved actives and authorised products in DE are more or less stable • However, in specific crops products are not available as needed. Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 2 Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 3 Number of approvals in DE high • Around 600 approvals in progress • Number of approvals has increased considerably • 250 new approvals in 2015 • Number of authorisations are clearly lower, therefore • Considerable delays in authorisation procedures • Accumulation of not finalised registration procedures Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 4 Reasons for higher number of applications • Applicants apply in DE because: – other MS accept only a certain number of applications – in DE authorities must accept all applications – authorisation are difficult to get in DE, but if yes, acceptance in other MS often high – applicants receive information about short-comings early in authorisation procedure – DE important market for PPP. Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 5 Current status of zonal procedures • According to 1107/2009 procedure should be finalised 12 (18) month after time of application • Nearly impossible to reach this goal • Authorities in DE busy in improving situation • FVO-Audit last week in Braunschweig: – number of applications, staff, Time of processing are requested – recommendations from FVO; action plan of MS to bedelivered – implementation will be supervised • COM will report to parliament next year . Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 6 Why are authorisation procedures delayed ? • A lot of new assessment methods and citeria for decisionmaking (Cutoffs, CfS, Comparative Assessment, …) • Development of guidance documents very science driven but often not ready for regulatory practise • Interpretation of GD parly unclear, no clear guidance given • Role of Risk Managers to be clarified • Needs of regulatory bodies are not enough considered Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 7 Why are authorisation procedures delayed ? • Quality of applications partly low • Applicants may wish to submit good applications to reduce workload in authorities • No clear arbitration procedure in central zone in place • Different opinions are discussed but if no agreement no further action Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 8 Reasons for long processing time • Completeness of evaluation in MS still different (Art. 36 (1)) • Efficacy assessment and wording/structure of GAPs need to be better harmonised • Still a considerable number of national approaches • When to apply new scientific and technical knowledge ? • Efforts for coordinating and organising approval procedure in DE are quite high • Not enough staff in authorities • Public discussions much more critical; workload for responding has increased considerably (e.g. glyphosate) Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 9 Measures taken for improving situation • More intensive check for completeness • Refuse applications of low quality • Increase work in groups like PAI, CZSC, DCG at EU and zonal level for more harmonisation • Start discussion on strengthening work of these groups • Clear remits and responsibilities of groups are needed and an effective work-sharing Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 10 Measures taken for improving situation • Taking the lead for projects aiming more harmonisation in RA and RM • More efforts for optimising process of GD development • More regular contacts with CA in neighbouring countries • Strengthening procedures in DE regulatory system • Increasing staff in regulatory bodies • But overall workload for harmonisation – in particular assessment and decision-making schemes – is high and needs time ! Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 11 Take home messages • Implementation of 1107/2009 increased work-sharing amongst MS and a considerable number of zonal authorisations were granted • High number of applications in DE • Processing time too long • More harmonisation for RA and RM needed • Clear Guidance ready for regulatory purpose needed • Measures to improve situation are presented. Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016 Seite 12 Thank you for your attention! Kontakt: Dr. Martin Streloke Telefon: 0531 299-3401 E-Mail: [email protected] Dr. Martin Streloke, BVL Abteilung Pflanzenschutzmittel 17. Februar 2016
© Copyright 2024 ExpyDoc